Zenas Yiu (@zznyiu) 's Twitter Profile
Zenas Yiu

@zznyiu

@OfficialUoM #Dermatology #RxEpi
@The_MRC Clinician Scientist
@CochraneSkin Associate Editor
@NICEComms TA D
Bluesky @ zznyiu.bsky.social

ID: 893125269321547776

linkhttp://personalpages.manchester.ac.uk/staff/zenas.yiu calendar_today03-08-2017 15:03:52

1,1K Tweet

1,1K Followers

1,1K Following

Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Nice early results from a small phase IIa trial on Bempikibart, IL7/TSLP inhibitor biologic for alopecia areata in the late breaking session by Brett King Looks like it results in more durable responses compared to JAK inhibitors after treatment cessation #AAD2025

Nice early results from a small phase IIa trial on Bempikibart, IL7/TSLP inhibitor biologic for alopecia areata in the late breaking session by Brett King

Looks like it results in more durable responses compared to JAK inhibitors after treatment cessation 

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Very high negative predictor values presented by Skin Analytics for their DERM AI device in ruling out melanoma I think gold standard for this based on dermatologist diagnosis is still suboptimal and would like longer term data with follow up #AAD2025

Very high negative predictor values presented by Skin Analytics for their DERM AI device in ruling out melanoma

I think gold standard for this based on dermatologist diagnosis is still suboptimal and would like longer term data with follow up

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

ESK-001 showing promise as a targeted inhibitor of TYK2 for psoriasis in a phase II trial - now for the phase III study to confirm findings for blinded primary outcome #AAD2025

ESK-001 showing promise as a targeted inhibitor of TYK2 for psoriasis in a phase II trial - now for the phase III study to confirm findings for blinded primary outcome 

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Much needed study to look at the impact of dupilumab on itch in epidermolysis bullosa and ichthyosis need a bigger study with a control arm but very promising! #AAD2025

Much needed study to look at the impact of dupilumab on itch in epidermolysis bullosa and ichthyosis

need a bigger study with a control arm but very promising!

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Icotrokinra showing high but slightly lower response rates compared to injectable IL23i for #psoriasis - nonetheless a very high effectiveness for an oral medication #AAD2025

Icotrokinra showing high but slightly lower response rates compared to injectable IL23i for #psoriasis - nonetheless a very high effectiveness for an oral medication

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Nice to see new therapies coming through for cutaneous lupus erythematosus - phase II data on deucravacitinib for CLE #AAD2025

Nice to see new therapies coming through for cutaneous lupus erythematosus - phase II data on deucravacitinib for CLE

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Slow and steady response for rocatinlimab, OX40 receptor inhibitor for atopic dermatitis Looks like it is quite targeted and safe in this phase III study - but if the thought is a slower response they probably needed to have a later primary outcome timepoint #AAD2025

Slow and steady response for rocatinlimab, OX40 receptor inhibitor for atopic dermatitis

Looks like it is quite targeted and safe in this phase III study - but if the thought is a slower response they probably needed to have a later primary outcome timepoint

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Much needed study on new therapies in bullous pemphigoid - more sustained remission for dupilumab after corticosteroid taper #AAD2025

Much needed study on new therapies in bullous pemphigoid - more sustained remission for dupilumab after corticosteroid taper 

#AAD2025
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Honoured to present on evidence based care in #psoriasis alongside amazing speakers for alopecia areata, urticaria, CTCL, acne, and photoaging at the #AAD2025 yesterday. Learnt a lot from all the speakers on the topics at hand as well as how to get complex messages across

Honoured to present on evidence based care in #psoriasis alongside amazing speakers for alopecia areata, urticaria, CTCL, acne, and photoaging at the #AAD2025 yesterday.

Learnt a lot from all the speakers on the topics at hand as well as how to get complex messages across
Dermatology_UKDCTN (@uk_dctn) 's Twitter Profile Photo

Grant award available to kick start your research. Funding theme for 2025 is Skin of colour in dermatology - Up to ÂŁ10K available

Grant award available to kick start your research.  Funding theme for 2025 is Skin of colour in dermatology - Up to ÂŁ10K available
movesmart_psoriasis_study (@movesmart_study) 's Twitter Profile Photo

We want to find out if MOVE SMART, a new lifestyle programme for patients with psoriasis, can help psoriasis and other conditions linked with psoriasis. If you would like to volunteer / find out more, please e-mail [email protected]. National Institute for Health and Care Research

Zenas Yiu (@zznyiu) 's Twitter Profile Photo

Interested in making a difference for people with #psoriasis in the UK? Apply for this Psoriasis Association funded PhD with me, Binh Phan, Richard Warren, and Gabriel Rogers and use data from BADBIR and trials to conduct cost-effectiveness analyses findaphd.com/phds/project/a…

The BMJ (@bmj_latest) 's Twitter Profile Photo

This article is the first in a series describing the fundamental points that authors of systematic reviews, health technology assessment reports, and clinical practice guidelines need to use the Core GRADE approach bmj.com/content/389/bm…

This article is the first in a series describing the fundamental points that authors of systematic reviews, health technology assessment reports, and clinical practice guidelines need to use the Core GRADE approach 
bmj.com/content/389/bm…
National Eczema Society (@eczemasociety) 's Twitter Profile Photo

We are thrilled to announce the winners of our first-ever research grant round, supporting innovative eczema research to improve understanding, care and outcomes for people living with the condition. In this round we have awarded 2 pump-priming awards and 2 PhD studentships.

We are thrilled to announce the winners of our first-ever research grant round, supporting innovative eczema research to improve understanding, care and outcomes for people living with the condition. 

In this round we have awarded 2 pump-priming awards and 2 PhD studentships.
NIHR Manchester Biomedical Research Centre (@manchesterbrc) 's Twitter Profile Photo

Congratulations to Dr Kirsty Rutter and Dr Zenas Yiu (Zenas Yiu) from our Dermatology Theme on being awarded one of the first-ever research grants from the National Eczema Society! 👏 Their project investigates how sunlight and other environmental factors affect eczema symptoms.

JAMA Dermatology (@jamaderm) 's Twitter Profile Photo

Adding methotrexate to adalimumab did not enhance the effectiveness or persistence of adalimumab treatment in adults with plaque psoriasis compared to adalimumab monotherapy. ja.ma/43BfCzG

Adding methotrexate to adalimumab did not enhance the effectiveness or persistence of adalimumab treatment in adults with plaque psoriasis compared to adalimumab monotherapy. ja.ma/43BfCzG
Zenas Yiu (@zznyiu) 's Twitter Profile Photo

We have a great #PhD opportunity with a multi-disciplinary supervisory team to understand the impact of UV radiation on #eczema #atopicdermatitis using methods from epidemiology, wearables, data science, and behavioural science Deadline 7/7/2025! findaphd.com/phds/project/e…

touchDERMATOLOGY (@touchderm) 's Twitter Profile Photo

🚀Celebrating the rising stars of dermatology! We are delighted to introduce the touchDERMATOLOGY Future Leaders 2025—some of the outstanding individuals shaping the future of our field. Read more: touchderma.com/insight/touchd… Congratulations to all the honorees!👏 #Dermatology

🚀Celebrating the rising stars of dermatology!

We are delighted to introduce the touchDERMATOLOGY Future Leaders 2025—some of the outstanding individuals shaping the future of our field.

Read more:
touchderma.com/insight/touchd…

Congratulations to all the honorees!👏

 #Dermatology
Donya Mighty (@itsdoctormighty) 's Twitter Profile Photo

Pls RT: If you are a PA or PA student wanting to apply to medicine, feel free to leave your details here to be added to an online mentorship group ran by myself and other PAs who have gone on to study medicine: forms.gle/VS9HBP4NZmsKS7… pls share among networks

Pls RT: If you are a PA or PA student wanting to apply to medicine, feel free to leave your details here to be added to an online mentorship group ran by myself and other PAs who have gone on to study medicine: forms.gle/VS9HBP4NZmsKS7… pls share among networks